Majhail N S, Parks K, Defor T E, Weisdorf D J
Blood and Marrow Transplant Program, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
Bone Marrow Transplant. 2006 Dec;38(11):765-8. doi: 10.1038/sj.bmt.1705521. Epub 2006 Oct 9.
Allogeneic hematopoietic cell transplantation (HCT) using reduced-intensity conditioning (RIC) has lower morbidity and mortality compared to transplantation using myeloablative conditioning (MAC). The syndrome of alveolar hemorrhage, a life-threatening pulmonary complication of HCT, has not been well described after RIC HCT. We reviewed prospectively collected data on 206 RIC and 1112 MAC HCT performed between 1995 and 2004 to study the impact of conditioning regimen on the clinical features and outcome of alveolar hemorrhage. Alveolar hemorrhage occurred in 18 RIC HCT recipients (cumulative incidence 8% (95% confidence intervals (CI), 5-11%)) and 85 MAC HCT recipients (cumulative incidence 7% (95% CI, 6-8%), P = 0.56). The clinical presentation of hemorrhage in both cohorts was similar. Survival at 60 days from the onset of hemorrhage was 28% (95% CI, 7-49%) for RIC group compared to 26% (95% CI, 17-35%) after MAC HCT (P = 0.56). Reducing the intensity of preparative regimen does not protect against post transplant alveolar hemorrhage. Alveolar hemorrhage occurring after RIC or MAC HCT has similar incidence, clinical presentation, and associated high mortality.
与采用清髓性预处理(MAC)的异基因造血细胞移植(HCT)相比,采用减低剂量预处理(RIC)的HCT具有更低的发病率和死亡率。肺泡出血综合征是HCT一种危及生命的肺部并发症,在RIC HCT后的情况尚未得到充分描述。我们回顾性分析了1995年至2004年间前瞻性收集的206例RIC HCT和1112例MAC HCT的数据,以研究预处理方案对肺泡出血的临床特征和结局的影响。18例RIC HCT受者发生肺泡出血(累积发生率8%(95%置信区间(CI),5-11%)),85例MAC HCT受者发生肺泡出血(累积发生率7%(95% CI,6-8%),P = 0.56)。两个队列中出血的临床表现相似。RIC组出血发生后60天的生存率为28%(95% CI,7-49%),而MAC HCT后为26%(95% CI,17-35%)(P = 0.56)。降低预处理方案的强度并不能预防移植后肺泡出血。RIC或MAC HCT后发生的肺泡出血具有相似的发生率、临床表现及相关的高死亡率。